Revista Peruana de Reumatología : Volumen 1 Nº 3, Año 1995 LIMA-PERU

 

Bibliografía

1.- Moore JE, Mohr CF: Biologically false positive serological test for syphilis: type, incidence and cause. J Chronic Dis. 1952; 150: 467-73.

2.- Coonley CL, Hartmann RC: A hemorrhagic disorder casued by circulating anticoagulant in patient disseminated Lupus Erythematosus. J Clin Invest. 1952; 31: 621-622

3.- Johansson EA et. al. A peripherial vascular syndrome overlapping with systemic lupus erythematosus. Dermatología 1977; 155: 257-63

4.- Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 1983; 287: 1088-89

5.- Mintz G, Acevedo Vásquez E, Gutierrez Espinoza G, Avelar Gamica F: Renal vein Thrombosis and inferior vena cava thrombosis in SLE. Arthritis Rheum 1984; 27: 539-44

6.- Hughes GRV, Harris EN, Gharavi AE: the anticardiolipin syndrome. J Rheumatol 1986;1 3:486-89

7.- Harris EN, Khamashta MA, Hughes GR: Antiphospholipid antibody syndrome. Arthritis and allied conditions. Twelfth edition. edited by DJ Mc Carty, WJ Coopman. Philadelphia, Lea & Febiger, 1993.

8.- Asherson RA: A "primary" antiphospholipid syndrome. J Rheumatol. 1988; 15: 1742-46.

9.- Alarcón Segovia D, Sanchez Guerrero J: Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-88.

10.- Feinstein DI, Rapaport SI: Acquired inhibitors of blood coagulation. Prog Hemost Thromb . 1972; 1: 75-95.

11.- Harris EN et al: Anticardiolipin antibodies : detection by radio-immunoassay and association with thrombosis in SLE. Lancet 1983; 2: 1211-13.

12.- Alarcón Segovia D, Cardiel M, Reyes E: Antiphospholipid arterial vasculopathy. J Rheumatol 1989; 16: 762-67.

13.- Asherson RA, Khamashta MA, Gil A et al.: Cerebrovascular disease and antiphospholipid antibodies in SLE, lupus like disease and the primary anti phospholipid syndrome. Am J Med 1989; 86: 391-99.

14.- Feinstein Dl: Lupus anticoagulant, thrombosis and fetal loss N. Eng J Med 1985; 313: 1348-50.

15.- Savin H, Huberman M, Kott E et al: Fibrosing alveolitis associated with primary antiphospholipid syndrome. Br J Rheumatol 1944; 33: 977-80.

16.- Lavalle C, Pizarro S, Drenkard C et al.: Transverse myelitis: a manifestation of SLE strongly associated with antiphospholipid antibodies. J Rheumatol 1990; 17: 34-37.

17.- Vianna JL, Khamashta MA, Ordi-Rios J et al: Comparison of the primary and secondary antiphospholipid syndrome: A european multicenter study of 114 patients. Am J Med 1994; 96: 3-9.

18.- Love PE, Santoro SA: Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in SLE and in non-SLE disorders. Ann intern Med 1990; 112: 682-98.

19.- Lockshin MD: Antiphospholipid antibodies syndrome. Rheum Dis Clin NA 1994; 20: 45-49.

20.- Hughes RA: The antiphospholipid syndrome. Ten years on. Lancet 1993; 342: 341-44.

21.- Weinstein C, Miller MH, Axtens R et al. Livedo reticularis associated with increased titers of anticardiolipin antibodies in SLE. Arch Dermatol 1987; 123:596-600.

22.- Grobb JJ San Marco M, Aillud MF et al: Unfading acral microlivedo. J Amm Acad Dermatol 1991; 24: 53-58.

23.- Sontheimer RD: The anticardiolipinsyndrome. Arch Dermatol 1987; 123: 590-94.

24.- Eng AM: Cutaneous expression of Antiphospholipid syndrome. Sem Throm Hem. 1994; 20: 71-78.

25.- Baum RA, Jundt JW: Intracardiac thrombosis and antiphospholipid antibodies: a case report and review of the literature. South Med J. 1994; 87: 928-32.

26.- Hamsten A, Norberg R, Bjorkholm M et al: Antibodies to cardiolipin in young survivors of myocardial infarction : an association with recurrent cardiovascular events. Lancet 1986; 1: 113-16.

27.- Asherson RA: The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508-12.

28.- Greisman SG, Thayaparan RS, Godwin TA et al: Occlusive vasculopathy in SLE: Association with anticardiolipin antibody. Arch Intern Med. 1991; 151: 389-92.

29.- Pelletier S, Landi B, Piette JC et al: Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol 1994; 21:71-78.

30.- Asherson RA, Cervera R: The anti phosphol ipid syndrome: a syndrome in evolution. Ann Rheum Dis 1992; 51: 147-50.

31.- Kwong T, Leonidas JC, llowite NT: Aymptomatic superior vena cava thrombosis and pulmonary embolism in an adolescent with SLE and anti phosphopholipid antibodies. Clin Esp Rheumatol 1944; 12: 215-17.

32.- Asherson RA, Morgan SH, Harris EN et al: Arterial occlusion causing large bowel infarction in SLE. Reflection of clotting diathesis. Clin Rheumatol 1986; 5: 102-06.

33.- Mor F, Beigel Y, Inbal A et al : Hepatic infarction in a patient with a lupus anticoagulant. Arthritis Rheum 1989; 32: 491-95.

34.- Montalban J Codina A, Ordi J et al: Antiphospholipid antibodies in cerebral ischemia. Stroke 1991; 22: 751-53.

35.- Deleze M, Oria CV, Alarcón-Segovia D: Ocurrence of both Hemolytic anemia and thrombocitopenia purpura (Evans Syndrome) in SLE. Relationship to antiphospholipid antibodies. J Rheumatol 1988; 15: 611-15.

36.- Levine SR, Langer SL, Albers JW et al: Sneddon's syndrome: an antiphospholipid antibodies syndrome?. Neurology. 1988; 38: 798.

37.- Piette JCh, Cacoub P, Wechsler B: Renal manifestation of the anti phospholpholipid syndrome. Semin Arthritis Rheum 1994; 23: 357-66.

38.- Amigo MC, Garcia-Torres R, Robles M et al: Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181.

39.- Carp HJA, Toder V, Mashiach S et al. Recurrent miscarriage: a review of currents concepts, immune mechanism and results of treatment. Obtet Gynecol 1991; 45: 657-67.

40.- Lubbe W, Liggins G: Lupus antigoagulant and pregnancy. Am J Obstet Gynecol 1985; 153: 324-27.

41.- Omstein MH, Rand JH: An association betwen refractory HELLP syndrome and antiphospholipid antibodies during pregnancy; a report of 2 cases. J Rheumatol 1994; 21: 1360-64.

42.- Tabbut S, Griswold WR, Ogino MT et al: Multiple thrombosis in a premature infant associated with maternal phospholipid antibodies syndrome. J Perinatol 1944; 14: 66-70.

43.- Boxer M, Ellman L, Carvalho A: The lupus anticoagulant. Arthritis Rheum 1976; 19: 1244-48.

44.- Lie JT. Vasculopathy in the antiphospholipid syndrome thrombosis or vasculitis, orboth? J Rheumatol 1989; 16: 713-14.

45.- Ruiz-Arguelles G, Riuz-Arguelles A, Alarcón-Segovia D et al: Natural anticoagulant in SLE. Deficiency of protein "S" bound to C4bp associates with recent history of venous thrombosis, antiphospholipid antibodies and antipohospholipid syndrome. J Rheumatol 1991; 18: 552-58.

46.- Violi F, Ferro D, Valesini G et al: Tissue plasminogen activator inhibitor in patients with SLE and thrombosis. Br M J 1990; 300: 1099-1102.

47.- Alarcon-Segovia D, Cabral AR: Antiphospholipid antibodies. Where do they come from? Where do they go? J Rheumatol 1994; 21: 982-89.

48.- Martinuzzo ME, Forastiero RR, Carreras LO: Anti beta 2 glycoprotein 1 antibodies : detection and association with thrombosis. Br J Haematol 1995; 89: 397-402.

49.- Ozawa N, Makino T, Matsubayashi H et al: Beta 2 glycoprotein 1 dependent and independent binding of anticardiolipin antibodies in patients with recurrent spontaneous abortions. J Clin Lab Anal 1994; 8: 255-59.

50.- Blank M, Tincani A, Shoenfeld Y: Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol 1994; 21: 100-04.

51.- Canoso RT, De Olivera RM: Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: Abscence of thrombosis. Am J Hematol 1988; 27: 272.

52.- Levy RA, Gharavi AE, Sammaritano LR et al : IgG antiphospholipid antibodies of patients with SLE and with Syphilis differ. J Rheumatol 1990; 17: 1036.

53.- Khamashta MA, Cuadrado MJ, Mujic Fetal: The management of thrombosis in the antiphospholipid syndrome. N Eng J Med 1995; 332: 993-97.

54.- Rivier GR, Herranz MT, Khamashta MA, Hughes GRV: Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus 1994; 79: 173-76.

55.- Vivaldi P, Andreotti C, Mazzon C, Pedrazzoli M: A "primitive" catastrophic anti phospholipid syndrome. Haematologica. 1994; 79: 173-76.

56.- Lubbe WF, Palmer SJ, Butler WS et al: Fetal survival after after prednisone suppresion of maternal lupus anticoagulant. Lancet 1983; 1: 1361.

57.- Brach DW, Sliver RM, Blackwell JL et al : Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80: 614-620.

58.- Ordi-Rios J, Perez-Peman P, Monasterio J: Clinical and therapeutic aspects associated to phospholipid binding antobodies (lupus anticoagulant and anticardiolipin antibodies). Haemostasis 1994; 24: 165-74.

59.- Acevedo-Vasquez E, Glave C, Pastor Asurza C: Sindrome antifosfolipido. V congreso Peruano de Reumatologia, 1988, Libro de Resumenes..

60.- Perich R, Acevedo E, Pastor C: Sindrome antifosfolipido, evolución y tratamiento. VII Congreso Peruano de Reumatologia, 1992, Libro de Resumenes.

 

Regresar al Artículo